Discovery of Quality Markers in Hugan Qingzhi Formula by Integrating a Lipid-Lowering Bioassay with UHPLC-QQQ-MS/MS.

Authors:
He F; Xiao CX; Wang CJ; Liang J; Cheng QQ and 3 more

Journal:
Evid Based Complement Alternat Med

Publication Year: 2020

DOI:
10.1155/2020/1594350

PMCID:
PMC8860508

PMID:
35198030

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Evid Based Complement Alternat Med

Abbreviation: Evid Based Complement Alternat Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Integrative & Complementary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Anti-Inflammatory Effects of <i>Clematis terniflora</i> Leaf on Lipopolysaccharide-Induced Acute Lu…
Park JY; Kim MJ; Choi YA and 6 more (2024) - Transparency Score: 3/6
Antiplatelet and Antithrombotic Activities of <i>Lespedeza cuneata</i> via Pharmacological Inhibiti…
Akram AW; Saba E; Rhee MH. (2024) - Transparency Score: 3/6
Biofilm-Inhibitory Activity of Wild Mushroom Extracts against Pathogenic Bacteria.
Gebreyohannes G; Sbhatu DB; Nyerere AK and 1 more (2024) - Transparency Score: 3/6
In Silico and In Vitro Studies of Antibacterial Activity of Cow Urine Distillate (CUD).
Pant L; Thapa S; Dahal B and 2 more (2024) - Transparency Score: 2/6
Phytochemistry Profile, Antimicrobial and Antitumor Potential of the Methanolic Extract of <i>Taber…
da Rosa E; Stopiglia CDO; Machado MM and 6 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure Fan He, Chun-Xin Xiaon, and Can-Jian Wang are the co-first authors. Conflicts of Interest The authors declare that there are no conflicts of interest regarding the publication of this article."

Evidence found in paper:

"This research was supported by the National Science Foundation of China (NSFC; no. 82074078) and the Science and Technology Project of Guangzhou (no. 201604020033)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025